
Vice President, Regulatory Affairs – CMC Large Molecule and Device Quality & Regulatory
Merck
Summary
We are seeking an exceptional leader to serve as Vice President, Regulatory Affairs – CMC Large Molecule and Device Quality & Regulatory, the single point of executive accountability for large molecule Regulatory CMC including Biologics, Vaccines, and devices/combination products. This position reports to the Senior Vice President, Regulatory, Chemistry, Manufacturing and Control (CMC) and Quality Assurance.
Job description
This role in Research and Development (R&D) operates at the critical intersection of Development, Manufacturing Operations, Science & Technology, Quality, and Supply Chain Management, establishing the regulatory vision and governing end-to-end execution across all development phases from First-in-Human clinical trials through commercial registrations (BLA, MAA, J-NDA). The role is also accountable for lifecycle management for large molecules and combination products.
Leading a multi-site organization of approximately 200 to 300 regulatory scientists and device quality professionals, the Vice President ensures that enterprise pipeline programs spanning monoclonal antibodies, bi-specifics, antibody-drug conjugates (ADCs), vaccines, and device/combination products are advanced with regulatory sciences rigor, speed, and compliance across global commercial markets. Direct reports include Associate Vice Presidents for Biologics and New Modalities, Vaccines, and Devices Quality and Regulatory.
Key Responsibilities
Strategic Leadership & Regulatory Accountability
- Lead establishment of regulatory CMC strategies from clinical through commercial phases for large molecule (biologics and vaccines) and new modalities including monoclonal antibodies, bispecifics, ADCs, and vaccines.
- Ensure integration of high quality scientific content and control strategies into regulatory filings to enable process robustness and life cycle maintenance.
- Provide leadership and direction for end-to-end global regulatory strategies and quality compliance for drug-device combination products, ensuring compliance with FDA and EU Regulations for autoinjectors, pre-filled syringes, and on-body delivery systems.
- Lead oversight for the authoring and delivery of Common Technical Document (CTD) Module 3 and Module 2.3 Quality Overall Summaries across IND, CTA, BLA, MAA, and post-approval filings.
- Partner with Regulatory CMC leadership to support the modernization of regulatory CMC workflows through structured data, component authoring and advanced digital tools.
Health Authority Interactions & Inspection Readiness
- Ensure effective preparation and engage in Health Authority interactions, and meetings with major regulatory agencies (FDA CDER/CBER, EMA) while representing the company externally to shape regulatory expectations.
- Lead or sponsor utilization of advanced regulatory working groups (such as the FDA Emerging Technology Program and EMA Innovation Task Force) to build early consensus on novel manufacturing and analytical methods.
- Partner with senior Quality leaders on inspection readiness programs, leading the regulatory strategy to prepare for Pre-Approval Inspections (PAIs) and responding to regulatory requests during GMP inspections or audits.
- Sponsor ensuring ISO certification and maintenance to enable effective combination product submissions, approvals and inspections.
Team Building & Talent Development
- Build, lead, and mentor a high-performing and inclusive regulatory CMC/device regulatory and quality team of scientists, managers, and experts.
- Foster a culture of innovative thinking and scientific excellence.
- Develop succession plans and talent pipelines aligned with organizational goals.
- Promote collaboration, knowledge sharing, and continuous learning.
Cross-Functional Collaboration & Stakeholder Management
- Partner and ensure effective cross functional collaboration to deliver submissions and approvals with key groups in development (Drug Substance, Pharmaceutical Sciences, Analytical Sciences and Quality Assurance) and Manufacturing, Quality, and Global Supply Chain.
- Serve as the primary regulatory partner for Large Molecule and Devices with cross functional leaders and ensure effective review of submissions by cross functional areas to gain alignment on strategy and content.
- Collaborate with Device Engineering and Human Factors teams to ensure design verification, validation, risk management files, and clinical usability assessments are properly embedded into Module 3 and device master files.
- Represent Regulatory CMC and Device Regulatory and Quality on key development and manufacturing governance forums and lead teams.
- Ensure effective regulatory CMC due diligence assessments, and integration plans for acquisitions, in-licensing and external co-development partnerships.
- Ensure effective collaboration and integration with other areas of Global Regulatory Affairs and Clinical Safety to deliver on submissions and approvals.
Team and Organizational Resource Management
- Manage resources effectively to ensure timely delivery of projects and submissions, while partnering with other leaders in Regulatory CMC to manage budgets and headcount targets.
- Oversee leaders and actively manage multiple regulatory submissions ensuring timely delivery, quality, and alignment with business priorities.
- Sponsor and collaborate on continuous improvement initiatives across the Regulatory CMC and enterprise to enable effective and efficient utilization of resources to maximize speed to market.
- Sponsor continuous improvement of the operating model for regulatory CMC activities in the US and globally to enable efficient regulatory deliverables.
Education
Advanced degree (Ph.D.) in Pharmaceutics, Chemical Engineering, Chemistry, Biochemistry, or related discipline is highly preferred. Alternatively a Master’s degree, PharmD or Bachelor of Science (B.S.) in Pharmacy, Chemical/Biomedical Engineering, Biochemistry, Chemistry, or a closely related discipline with extensive (+20 years) relevant biopharmaceutical industry experience is acceptable.
Required Experience and Skills
- Successful applicants would typically have 15 years to 25 yrs of progressive biopharmaceutical industry leadership experience, including 10 to 15 years in regulatory CMC leadership roles at various stages of development and commercialization.
- Demonstrated experience leading regulatory CMC strategy and contributing to the authoring and successful approval of marketing applications (e.g., BLAs, MAAs, J-NDAs, NMPA filings) and lifecycle supplements for biologics or large molecule programs.
- Experience in achieving successful outcomes through formal interactions (FDA and EMA) with major global regulatory agencies.
- Strong technical fluency in biologics drug substance, drug product and analytical for monoclonal antibodies, bispecifics, or ADCs.
- Demonstrated success leading large, multi site organizations across North America and/or Europe.
- Experience leading organizational changes, efficiency improvements or changes in work processes.
- Strong communication, collaboration and consensus building skills, including the ability to articulate complex technical issues clearly to executive leadership and regulatory authorities.
- Excellent business acumen and decision making that demonstrates an ability to translate complex technical and regulatory challenges into pragmatic, risk-mitigated strategies that align with enterprise business objectives.
- Commitment to talent development and building succession depth, championing inclusion, while fostering a culture of technical rigor and continuous learning.
Preferred Experience and Skills
- Direct leadership experience navigating drug-device combination products, autoinjectors, and pre-filled syringes under US (21 CFR Part 4/820) and EU (MDR 2017/745) requirements.
- Direct leadership experience implementing analytical comparability (ICH Q5E), and modern lifecycle guidelines (ICH Q8 through Q14).
- Experience leading cross-modality regulatory CMC teams including biologics, vaccines and device/combination products.
Location
This role will be based in either Upper Gwynedd, PA or Rahway, NJ & Hybrid company hub locations. Additional European locations with Hybrid on-site presence will be considered. Travel Expectations include up to 25% across Domestic & International locations including but not limited to New Jersey, Pennsylvania, Delaware, Switzerland, Ireland, and other locations.
Requirements
- Advanced degree (Ph.D.) in Pharmaceutics, Chemical Engineering, Chemistry, Biochemistry, or related discipline highly preferred; alternatively Master’s, PharmD, or B.S. with extensive (+20 years) relevant biopharmaceutical industry experience
- 15 to 25 years of progressive biopharmaceutical industry leadership experience
- 10 to 15 years in regulatory CMC leadership roles across development and commercialization stages
- Demonstrated experience leading regulatory CMC strategy and contributing to authoring and successful approval of marketing applications (BLAs, MAAs, J-NDAs, NMPA filings) and lifecycle supplements for biologics or large molecule programs
- Experience achieving successful outcomes through formal interactions with FDA and EMA
- Strong technical fluency in biologics drug substance, drug product and analytical for monoclonal antibodies, bispecifics, or ADCs
- Demonstrated success leading large, multi-site organizations across North America and/or Europe
- Experience leading organizational changes, efficiency improvements or changes in work processes
- Strong communication, collaboration and consensus building skills
- Excellent business acumen and decision making
- Commitment to talent development and building succession depth
- Preferred: Direct leadership experience navigating drug-device combination products, autoinjectors, and pre-filled syringes under US (21 CFR Part 4/820) and EU (MDR 2017/745) requirements
- Preferred: Direct leadership experience implementing analytical comparability (ICH Q5E) and modern lifecycle guidelines (ICH Q8 through Q14)
- Preferred: Experience leading cross-modality regulatory CMC teams including biologics, vaccines and device/combination products
Benefits
- Medical, Dental & Vision
- Retirement Benefits
- 401(k)
- Paid Holidays
- Vacation
- Compassionate & Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.